My previous article touted the fact that, while the munKNEE.com Pure-Play Pot Stock Portfolio was down 12.8%, on average, YTD, there were 10 stocks that went up 57.2%, on average, during the same 8-month period. This is a companion article which highlights the other side of the coin - 10 stocks in the portfolio that have declined between 29% and 64% (-44.7%, on average,) YTD.

The Pure-Play Pot Stock Portfolio consists of the 25 companies that derive 100% of their revenue from the sale of cannabis or cannabis consumption products and consistently trade for at least US$1/share to reflect the true health of the marijuana industry in the U.S. and Canada. 

The 10 losers YTD are as follows, in descending order:

1. Aurora (ACB) -64.1%
2. Tilray (TLRY) -62.3%
3. Harvest Health (HRVSF) -57.8%
4. Charlotte's Web (CWBHF) -57.4%
5. Medicine Man (SHWZ) -53.7%
6. Avicanna (AVCNF) -51.5%
7. Acreage (ACRGF) -51.0%
8. Organigram (OGI) -49.8%
9. Valens (VLNCF) -35.9%
10. Cronos (CRON) -28.9%

Canopy, Aphria, Cresco, Greenlane and Neptune also declined 22.2%, 8.4%, 6.9%, 5.8% and 3.6% respectively.

Interestingly, four of the 10 under-performers YTD are in the Vertically Integrated (Seed-to-Sale) Category of Canadian Licensed Producers (LPs) which is down 42.9% YTD, on average, while only three are in the American Multi-State Operators (MSOs) category which is UP 21.3% YTD . 

Please leave any views or questions you have in the Comments section below. Thank you.